{"product_id":"global-circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market-growth-status-and-outlook-2023-2029","title":"Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eCirculating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.\u003c\/p\u003e\n\n\u003cp\u003eCancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.\u003cbr\u003e\nLPI (LP Information)' newest research report, the “Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Forecast” looks at past sales and reviews total world Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) sales in 2022, providing a comprehensive analysis by region and market sector of projected Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) sales for 2023 through 2029. With Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry.\u003cbr\u003e\nThis Insight Report provides a comprehensive analysis of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market.\u003cbr\u003e\nThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs).\u003cbr\u003e\nThe global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size is projected to grow from US$ 14070 million in 2022 to US$ 57240 million in 2029; it is expected to grow at a CAGR of 22.2% from 2023 to 2029.\u003cbr\u003e\nThe major players in global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market include Janssen, Qiagen, Advanced Cell Diagnostics, etc. North America and Europe are main markets, they occupy about 65% of the global market. CellSearch is the main type, with a share about 70%. Breast Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment are main applications, which hold a share about 60%.\u003cbr\u003e\nThis report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market by product type, application, key players and key regions and countries.\u003cbr\u003e\nMarket Segmentation:\u003cbr\u003e\nSegmentation by type\u003cbr\u003e\n CellSearch\u003cbr\u003e\n Others\u003cbr\u003e\nSegmentation by application\u003cbr\u003e\n Breast Cancer Diagnosis and Treatment\u003cbr\u003e\n Prostate Cancer Diagnosis and Treatment\u003cbr\u003e\n Colorectal Cancer Diagnosis and Treatment\u003cbr\u003e\n Lung Cancer Diagnosis and Treatment\u003cbr\u003e\n Other Cancers Diagnosis and Treatment\u003cbr\u003e\nThis report also splits the market by region:\u003cbr\u003e\n Americas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\n APAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\n Europe\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\n Middle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003cbr\u003e\nThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\n Janssen\u003cbr\u003e\n Qiagen\u003cbr\u003e\n Advanced Cell Diagnostics\u003cbr\u003e\n ApoCell\u003cbr\u003e\n Biofluidica\u003cbr\u003e\n Clearbridge Biomedics\u003cbr\u003e\n CytoTrack\u003cbr\u003e\n Celsee\u003cbr\u003e\n Fluxion\u003cbr\u003e\n Gilupi\u003cbr\u003e\n Cynvenio\u003cbr\u003e\n On-chip\u003cbr\u003e\n YZY Bio\u003cbr\u003e\n BioView\u003cbr\u003e\n Fluidigm\u003cbr\u003e\n Ikonisys\u003cbr\u003e\n AdnaGen\u003cbr\u003e\n IVDiagnostics\u003cbr\u003e\n Miltenyi Biotec\u003cbr\u003e\n ScreenCell\u003cbr\u003e\n Silicon Biosystems\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 124 Pages \/ MCW16226149","offer_id":47640120787250,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}